Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Shionogi investigates new cephem compounds

Feb. 19, 1998

KY-62 evaluated in murine models of candidiasis

Feb. 18, 1998

Cubist outlines development plans for daptomycin

Feb. 18, 1998

SKB and WHO join forces to wipe out lymphatic filariasis

Feb. 18, 1998

Patients sought for GS-4104 clinical study

Feb. 17, 1998

Amphocil marketing agreement signed for Mexico

Feb. 16, 1998

Imiquimod for selftreatment of external anogenital warts

Feb. 16, 1998

Micrologix, PENCE to collaborate on new antibiotics

Feb. 12, 1998

Synercid scheduled for FDA committee review next week

Feb. 12, 1998

Roche develops orally active anti-HSV agent that targets viral TK

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...